author-photo

Sally Moore

University College Hospital

4

Papers

22

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Factors Influencing Outcomes of Relapse from Front-Line Autologous Stem Cell Transplant (ASCT) over a 14 Year Period: A Single Centre Experience

2016 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Single Centre Analysis Of Autologous Stem Cell Transplant Outcomes In Multiple Myeloma In 338 Consecutive Patients: Maintenance/Consolidation Is Associated With Superior Survival, But Early Relapse Is The Single Most Important Predictor Of Survival and May Override Genetic Risk

2013 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma.

2013 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (11)
Mini-BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory DLBCL

2012 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (10)